ClassID:

21487

A61K49/124 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Macromolecular compounds dendrimers, dendrons, hyperbranched compounds

Recent Application in this class:
#1
20250152753
2025-05-15

FORMULATION OF CONTRAST MEDIA AND PROCESS OF PREPARATION THEREOF

#2
20240252690
2024-08-01

Formulation of contrast media and process of preparation thereof

#3
20240156998
2024-05-16

RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE

#4
20220259244
2022-08-18

COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS

#5
20220008562
2022-01-13

Formulation of contrast media and process of preparation thereof

#6
20210330600
2021-10-28

NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME

#7
20210236661
2021-08-05

Cyclodextrin-linked polyvalent ligands for complexation of metal ions

#8
20210052749
2021-02-25

AMPHIPHILIC POLYMER NANO MICELLE CONTAINING POLY-3,4-DIHYDROXYPHENYLALANINE CHELATED FERRIC IONS

#9
20200330613
2020-10-22

SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF

#10
20200190265
2020-06-18

Biodegradable dendritic structure, methods and uses thereof

#11
20200079806
2020-03-12

Compounds for use as iron(III) MRI contrast agents

#12
20190060490
2019-02-28

PAMAM dendrimer based CEST imaging agents and uses thereof

#13
20190038782
2019-02-07

Brush-arm star polymer imaging agents and uses thereof

#14
20180264143
2018-09-20

Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof

#15
20180154025
2018-06-07

Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures

#16
20180021462
2018-01-25

Homing agents

#17
20170209602
2017-07-27

Method and compositions for orally administered contrast agents for MR imaging

#18
20170035916
2017-02-09

Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers

#19
20160175464
2016-06-23

Branched amphipathic block polymer and molecular aggregate and drug delivery system using same

#20
20150225439
2015-08-13

Dendrimer scaffolds for pharmaceutical use

#21
20150224206
2015-08-13

N-BOC-dendrimers and their conjugates

#22
20150202327
2015-07-23

Molecular assembly using branched amphiphilic block polymer, and drug transportation system

#23
20150071863
2015-03-12

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

#24
20150023872
2015-01-22

Homing agents

#25
20140363376
2014-12-11

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

#26
20140350193
2014-11-27

Manganese comprising nanostructures

#27
20140336368
2014-11-13

Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging

#28
20140127132
2014-05-08

Branched amphipathic block polymer and molecular aggregate and drug delivery system using same

#29
20140056822
2014-02-27

DNA Dendrimers as Thermal Ablation Devices

#30
20140023594
2014-01-23

MRI contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same

#31
20140004048
2014-01-02

Water-soluble nanoparticles

#32
20130197271
2013-08-01

Dendrimers and methods of preparing same through proportionate branching

#33
20130095035
2013-04-18

Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis

#34
20130030139
2013-01-31

Dendritic polymers and magnetic resonance imaging contrast agent employing the same

#35
20120328512
2012-12-27

Fibrin-binding peptides and conjugates thereof

#36
20120294809
2012-11-22

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

#37
20120259098
2012-10-11

Dendrimer compositions and methods of synthesis

#38
20120244070
2012-09-27

Fibronectin targeting contrast agent

#39
20110268731
2011-11-03

Methods of treating autoimmune disorders and/or inflammatory disorders

#40
20110256067
2011-10-20

Contrast agents endowed with high relaxivity

#41
20110123457
2011-05-26

CONJUGATES OF 19F MR IMAGING TRACERS AND CHEMOTHERAPEUTIC AGENTS FOR DRUG QUANTIFICATION AND DRUG DOSE INDIVIDUALIZATION

#42
20110038805
2011-02-17

COMPOUNDS COMPRISING PARAMAGNETIC CHELATES ARRANGED AROUND A CENTRAL CORE AND THEIR USE IN MAGNETO RESONANCE IMAGING AND SPECTROSCOPY

#43
20100278750
2010-11-04

Polylysine dendrimer contrast agent

#44
20100256404
2010-10-07

Contrast agent containing silsesquioxane

#45
20100249350
2010-09-30

Hyperbranched polymer having nitroxyl group

#46
20100233096
2010-09-16

METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES AND SULPHONATES

#47
20100204508
2010-08-12

DENDRITIC COMPOUND AND USE THEREOF

#48
20100202967
2010-08-12

Fibrin binding peptide conjugates for diagnostic and therapeutic applications

#49
20100158814
2010-06-24

Fibrin-binding peptides and conjugates thereof

#50
20100135909
2010-06-03

DENDRIMERS AND METHODS OF MAKING AND USING THEREOF

#51
20100104512
2010-04-29

Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same

#52
20100056776
2010-03-04

Method of preparing macromolecular contrast agents and uses thereof

#53
20100008864
2010-01-14

AROMATIC MULTIMERS

#54
20090264397
2009-10-22

Highly fluorinated oils and surfactants and methods of making and using same

#55
20090196829
2009-08-06

Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of use as MRI contrast agents

#56
20090169481
2009-07-02

Dendritic polymers and magnetic resonance imaging contrast agent employing the same

#57
20090169480
2009-07-02

DENDRITIC POLYMERS AND MAGNETIC RESONANCE IMAGING CONTRAST AGENT EMPLOYING THE SAME

#58
20090023928
2009-01-22

PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS

#59
20090010845
2009-01-08

Polybiotin compounds of magnetic resonance imaging and drug delivery

#60
20080260649
2008-10-23

Method of dynamic nuclear polarisation (DNP)

#61
20080213187
2008-09-04

NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

#62
20080200799
2008-08-21

MRI involving contrast agent with time modulated contrast enhancement

#63
20080193384
2008-08-14

Responsive MRI contrast agents

#64
20070258905
2007-11-08

Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents

#65
20070248547
2007-10-25

CASCADE MACROMOLECULAR CONTRAST AGENTS FOR MEDICAL IMAGING

#66
20070185311
2007-08-09

Peptide-Based Multimeric Targeted Contrast Agents

#67
20070098643
2007-05-03

Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates

#68
20070098631
2007-05-03

DIAGNOSTIC COMPOUNDS COMPRISING A SCAFFOLD COUPLED TO A SIGNAL ENTITY FOR MEDICAL IMAGING DIAGNOSTIC

#69
20070077197
2007-04-05

Metal complexes derivatized with folate for use in diagnostic and therapeutic applications

#70
20070053840
2007-03-08

Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents

#71
20060275217
2006-12-07

Chemical exchange saturation transfer contrast agents

#72
20060239926
2006-10-26

Specific high-relaxivity compounds

#73
20060204443
2006-09-14

Methods for tumor treatment using dendrimer conjugates

#74
20060165601
2006-07-27

Dendritic compound and use thereof

#75
20060073101
2006-04-06

Method for convection enhanced delivery of therapeutic agents

#76
20060039861
2006-02-23

Peptide-based multimeric targeted contrast agents

#77
20050260127
2005-11-24

Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic

#78
20050171424
2005-08-04

Methods for imaging the lymphatic system using dendrimer-based contrast agents

#79
20050136008
2005-06-23

Polybiotin compounds for magnetic resonance imaging and drug delivery

#80
20050118105
2005-06-02

Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them

#81
20050074411
2005-04-07

Peptide-based multimeric targeted contrast agents

#82
20050058604
2005-03-17

Phthalamide-lanthanide complexes for use as luminescent markers

#83
20050019267
2005-01-27

Macromolecular imaging agents for liver imaging